Wave Life Sciences to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., April 05, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, will be participating at the following conferences:
|
H.C. Wainwright & Co. Global Life Sciences Conference April 9th at 9:00 a.m. CEST – Monte Carlo, Monaco Leerink Partners’ CNS Day April 18th at 10:00 a.m. EST – New York, NY |
About Wave Life Sciences
Wave Life Sciences is a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases. Our chemistry platform enables the creation of highly specific, well characterized oligonucleotides designed to deliver superior efficacy and safety across multiple therapeutic modalities. Our pipeline is initially focused on neurological disorders and extends across several other therapeutic areas. For more information, please visit www.wavelifesciences.com.
Investor Contact:
Jillian Connell
617-949-2981
jconnell@wavelifesci.com
Media Contact:
Jose Juves
617-949-4708
jjuves@wavelifesci.com
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
